ClinicalTrials.gg
CompletedNCT07943689Updated Nov 17, 2026

Effects of Etidronic Acid Concentration and EDDY Activation on Postoperative Pain and 12-Month Radiographic Outcomes in Apical Periodontitis

An interventional study of 17% EDTA and 9% HEDP-NaOCl in Chronic Apical Periodontitis, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Cukurova University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Mar 2025, registered Nov 2026).
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Periapical Periodontitis with a site in Turkey — 13 open to participants now, 20 under way, none of them phase 3. Periapical Periodontitis · Turkey.

Enrollment
12th of 75
132 · median 66
Started
2025
with 14 others
No phase
73 of 81
11 open now
Registered
81st of 81
by date

Among the 81 studies in Periapical Periodontitis with a site in Turkey, this one is the 12th largest by enrollment of the 75 interventional ones that give a count, is one of 15 that started in 2025, is one of 73 with no phase, and was the 81st registered.

Periapical Periodontitis

281 studies on the registry are indexed under Periapical Periodontitis; 79 are open to participants now.

Browse Periapical Periodontitis studies →

Open to participants now

13 of the 81 studies in Periapical Periodontitis with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 43 Periapical Periodontitis studies recruiting now, 17 (40%) set no upper age limit and 25 (58%) stop at 75 or younger; 5 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Periapical Periodontitis with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this randomized controlled clinical trial is to evaluate the effects of different concentrations of etidronic acid (HEDP) combined with sodium hypochlorite (NaOCl), with or without EDDY sonic activation, on postoperative pain and 12-month clinical and radiographic outcomes in adults undergoing single-visit root canal treatment for chronic apical periodontitis.

The main questions it aims to answer are:

Do different final irrigation protocols using 17% EDTA, 9% HEDP-NaOCl, or 18% HEDP-NaOCl affect postoperative pain during the first 72 hours after root canal treatment?

Does EDDY sonic activation influence postoperative pain compared with conventional syringe irrigation?

Does the effect of the final irrigation solution on postoperative pain differ according to whether EDDY activation is applied?

Do the different final irrigation protocols affect analgesic consumption during the first 72 hours after treatment?

Do these irrigation protocols influence clinical and radiographic periapical healing at 12 months, as assessed by the Periapical Index (PAI) and fractal dimension (FD) analysis?

Participants will be randomly assigned to one of six groups before root canal treatment.

Group 1: Final irrigation with 17% EDTA using conventional syringe irrigation without sonic activation.

Group 2: Final irrigation with 17% EDTA combined with EDDY sonic activation.

Group 3: Final irrigation with 9% HEDP-NaOCl using conventional syringe irrigation without sonic activation.

Group 4: Final irrigation with 9% HEDP-NaOCl combined with EDDY sonic activation.

Group 5: Final irrigation with 18% HEDP-NaOCl using conventional syringe irrigation without sonic activation.

Group 6: Final irrigation with 18% HEDP-NaOCl combined with EDDY sonic activation.

All participants will undergo single-visit root canal treatment using the same standardized endodontic treatment protocol. Root canal preparation will be performed using reciprocating nickel-titanium instruments, followed by the assigned final irrigation protocol.

In all groups, 5 mL of the assigned final irrigation solution will be applied for 60 seconds. In the sonic activation groups, the irrigation solution will be activated using the EDDY system in three consecutive 20-second cycles. In the non-activation groups, conventional syringe irrigation will be performed for 60 seconds without sonic activation.

Postoperative pain will be assessed using a 0-10 visual analog scale (VAS) at 6, 12, 24, 48, and 72 hours after treatment. The primary outcome will be the postoperative pain trajectory across these five time points, including comparisons of pain intensity between the six irrigation protocols.

Analgesic consumption during the first 72 hours will be recorded as a secondary outcome.

Clinical follow-up examinations will be performed at 3 and 6 months, followed by clinical and radiographic evaluations at 12 months. Periapical healing will be assessed by comparing baseline and 12-month PAI scores and evaluating radiographic changes using fractal dimension analysis. Clinical signs and symptoms, including spontaneous pain, percussion and palpation sensitivity, swelling, and sinus tract formation, will also be evaluated at the 12-month follow-up.

03

Conditions studied

  • Chronic Apical Periodontitis
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-65 years.
  • (ASA) physical status classification I or II.
  • Presence of a mature, single-rooted mandibular premolar tooth with a single root canal.
  • Diagnosis of pulp necrosis and chronic apical periodontitis, supported by clinical and radiographic findings, with no response to cold testing or electric pulp testing.
  • Baseline Periapical Index (PAI) score of 3, 4, or 5.
  • Absence of preoperative pain, defined as a visual analog scale (VAS) score of 0.
  • Affected tooth considered restorable and suitable for preservation following root canal treatment.
  • Provision of written before enrollment.

Exclusion criteria

Exclusion Criteria:

  • classification III or higher, or presence of a severe uncontrolled systemic disease that could affect endodontic treatment or outcome assessment.
  • Use of antibiotics, analgesics, anti-inflammatory medications, or within seven days before treatment.
  • Requirement for antibiotic prophylaxis before dental treatment due to a risk of infective endocarditis or another medical indication.
  • Presence of preoperative pain (VAS score greater than 0).
  • Presence of acute apical abscess, intraoral or extraoral swelling, or a sinus tract associated with the affected tooth.
  • Mandibular premolar teeth with multiple roots or root canals, or incomplete root development.
  • Presence of root fracture or root resorption.
  • Advanced periodontal disease, pathological tooth mobility, or periodontal pathology that could compromise treatment prognosis.
  • Teeth considered non-restorable.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    17% EDTA

    Participants assigned to this group received conventional final root canal irrigation with 5 mL of 17% ethylenediaminetetraacetic acid (EDTA) for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 17% EDTA

  • Experimental
    17% EDTA + EDDY

    Participants assigned to this group received final root canal irrigation with 5 mL of 17% ethylenediaminetetraacetic acid (EDTA) combined with EDDY sonic activation. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 17% EDTA · Device: EDDY Sonic Activation

  • Experimental
    9% HEDP-NaOCl

    Participants assigned to this group received conventional final root canal irrigation with 5 mL of 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 10 mL of 2.5% NaOCl. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 9% HEDP-NaOCl

  • Experimental
    9% HEDP-NaOCl + EDDY

    Participants assigned to this group received final root canal irrigation with 5 mL of 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution combined with EDDY sonic activation. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 10 mL of 2.5% NaOCl. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 9% HEDP-NaOCl · Device: EDDY Sonic Activation

  • Experimental
    18% HEDP-NaOCl

    Participants assigned to this group received conventional final root canal irrigation with 5 mL of 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 5 mL of 2.5% NaOCl. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 18% HEDP-NaOCl

  • Experimental
    18% HEDP-NaOCl + EDDY

    Participants assigned to this group received final root canal irrigation with 5 mL of 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution combined with EDDY sonic activation. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 5 mL of 2.5% NaOCl. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.

    Drug: 18% HEDP-NaOCl · Device: EDDY Sonic Activation

Interventions

  • Drug17% EDTA

    A 17% ethylenediaminetetraacetic acid (EDTA) solution (ENDO-SOLUTION, Cerkamed, Stalowa Wola, Poland) was used as a final root canal irrigant. A total of 5 mL of the solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.

  • Drug9% HEDP-NaOCl

    A 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution was used as a final root canal irrigant. The solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP (Medcem GmbH, Weinfelden, Switzerland) in 10 mL of 2.5% NaOCl. A total of 5 mL of the prepared solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.

  • Drug18% HEDP-NaOCl

    A 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution was used as a final root canal irrigant. The solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP (Medcem GmbH, Weinfelden, Switzerland) in 5 mL of 2.5% NaOCl. A total of 5 mL of the prepared solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.

  • DeviceEDDY Sonic Activation

    The EDDY sonic irrigation activation system (EDDY®, VDW GmbH, Munich, Germany) was used to activate the assigned final root canal irrigation solution (17% EDTA, 9% HEDP-NaOCl, or 18% HEDP-NaOCl). The EDDY tip was inserted into the root canal and positioned 2 mm short of the working length. Sonic activation was performed in three consecutive 20-second cycles, providing a total activation time of 60 seconds. A total of 5 mL of the assigned irrigation solution was used during the final irrigation procedure. Following activation, the root canal was flushed with 2.5 mL of distilled water to remove residual irrigants.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Over 72 Hours

    Postoperative pain intensity was assessed using a patient-reported 0-10 visual analog scale (VAS), where 0 indicated no pain and 10 indicated unbearable pain. Pain scores were recorded at 6, 12, 24, 48, and 72 hours after completion of single-visit root canal treatment. The primary outcome was the postoperative pain trajectory across these five time points, including differences in pain intensity between the six randomized final irrigation protocols.

    Time frame: 6, 12, 24, 48, and 72 hours after root canal treatment

Secondary outcomes

  1. Analgesic Consumption Within 72 Hours After Root Canal Treatment

    Analgesic consumption was assessed during the first 72 hours after root canal treatment. Participants were instructed to take 400 mg ibuprofen as needed for postoperative pain and to record the timing and number of tablets consumed. Analgesic use was evaluated by recording whether participants required analgesic medication and the total number of tablets consumed during the 72-hour follow-up period.

    Time frame: Within 72 hours after root canal treatment

  2. Change in Periapical Index (PAI) Scores From Baseline to 12 Months

    Periapical radiographic status was assessed using the Periapical Index (PAI), an ordinal scoring system ranging from 1 (normal periapical structures) to 5 (severe apical periodontitis with exacerbating features). Standardized periapical radiographs obtained at baseline and 12 months after root canal treatment were independently evaluated by two observers. Disagreements were resolved by consensus. Changes in PAI scores from baseline to 12 months were assessed to evaluate radiographic periapical healing across the six final irrigation protocols. Lower PAI scores indicate more favorable periapical conditions.

    Time frame: Baseline and 12 months after root canal treatment

  3. Change in Periapical Fractal Dimension (FD) From Baseline to 12 Months

    Fractal dimension (FD) analysis was performed on periapical radiographs obtained at baseline and 12 months after root canal treatment to quantitatively assess changes in periapical bone trabecular pattern complexity. Standardized regions of interest were selected in corresponding anatomical areas using ImageJ software. FD values were calculated for both time points, and the change was determined by subtracting the baseline FD value from the 12-month FD value. FD changes were compared among the six final irrigation protocols. FD values were interpreted as measures of radiographic structural complexity rather than direct indicators of treatment success or failure.

    Time frame: Baseline and 12 months after root canal treatment

  4. Clinical Healing Status at 12 Months

    Clinical healing was evaluated 12 months after root canal treatment based on the absence of spontaneous pain, tenderness to percussion or palpation, swelling, and sinus tract formation. Participants were classified as having achieved clinical healing when all assessed signs and symptoms were absent. The proportion of participants achieving clinical healing was evaluated across the six randomized final irrigation protocols.

    Time frame: 12 months after root canal treatment

  5. Radiographic Periapical Healing Status at 12 Months

    Radiographic periapical healing was assessed by comparing baseline and 12-month periapical radiographs. Radiographic outcomes were classified into three categories: complete healing, healing in progress, and no healing or worsening. The distribution of these radiographic healing categories was evaluated across the six randomized final irrigation protocols.

    Time frame: Baseline and 12 months after root canal treatment

07

Study locations

1 site
  • Cukurova University
    Adana, Sarıçam 01250, Turkey (Türkiye)
08

References and documents

Publications

  • Akyuz IE, Eminsoy Avci AT, Ustun Y, Kolcakoglu KS, Kizilci E. Evaluation of the effect of different irrigation solutions used in regenerative endodontic treatment of necrotic molar teeth with open apex on postoperative pain- randomized clinical trial. Clin Oral Investig. 2025 Jan 16;29(1):66. doi: 10.1007/s00784-025-06153-3. PubMed 39815035 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Aug 2025, 5 months.

Of 172 non-industry interventional studies with no phase under Periapical Periodontitis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's 5 months is below that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 6 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartActual
Mar 12, 2025
Primary completionActual
Aug 25, 2025
CompletionActual
Aug 28, 2025
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943689
Responsible party
Kübra Gürler (Principal Investigator, Cukurova University) — Principal investigator
First posted
Nov 17, 2026
Start date
Mar 12, 2025
Primary completion
Aug 25, 2025
Completion
Aug 28, 2025
Last update
Nov 17, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion